Citeline Podcasts

https://scrip.pharmaintelligence.informa.com/SC147283/Quick-Listen-Scrips-Five-MustKnow-Things

China Biotech Podcast102822 by Citeline

https://scrip.pharmaintelligence.informa.com/SC147243/Quick-Listen-Scrips-Five-MustKnow-Things

Medtech Insight’s new series Getting Personal features conversations with new and veteran senior executives about their journeys to corporate leadership, their motivations, passions and the peaks and valleys of running a medtech company. Daniel Hawkins, founder and CEO of Avail Medsystems discussed how his company virtually connects health care professionals into the operating suite and allows for real-time collaboration.

Pink Sheet reporters and editors discuss lessons from the public hearing on the proposed withdrawal of the preterm birth prevention drug Makena, FDA Commissioner Califf’s opinion that industry is not meeting expectations with accelerated approval confirmatory studies, and agency efforts to clarify that staff is paying attention to comparative claims in product ads.

In this month’s Digital Health Roundup, Medtech Insight’s Reed Miller offers a recap from the recent TCT 2022 meeting and talks about Butterfly Network’s expansion into Africa while Marion Webb highlights her interview with Aidoc’s CEO Elad Walach discussing plans for the AI-based software company.

Listen to the podcast via the player below:

Medtech Insight articles addressing topics discussed in this episode:

AI-based Start-Up Aidoc Has Big Plans For Health Integration Beyond Reading Radiology Scans

Minute Insight: Butterfly Deploys POC Ultrasound In Kenya To Support New Mothers

Cardio Catch-Up: Medtech Innovation Takes Center Stage At TCT 2022

In this new series titled Getting Personal, we talk to new and veteran senior executives about their journeys to corporate leadership, their motivations, passions, and the peaks and valleys of running a medtech company. Medtech Insight sat down with Mike Mussallem, CEO of Edwards Lifesciences, the leading seller of transcatheter aortic valve replacement (TAVR) devices, at the company’s Irvine, CA-based headquarters.

https://scrip.pharmaintelligence.informa.com/SC147207/Quick-Listen-Scrips-Five-MustKnow-Things

Pink Sheet reporters and editors discuss Michelle McMurry-Heath’s surprising departure as head of a top biotech industry trade association, preview the FDA hearing to withdraw the preterm birth prevention drug Makena, and consider Amylyx’s Relyvrio seemingly opening a wider path to gather confirmatory evidence for approval.

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。

今回取り上げた記事はこちら

A Banner Moment For Alzheimer's Positions Eisai/Biogen At The Head Of The Pack

（邦題意訳「アルツハイマー治療薬　エーザイとバイオジェンに競争の栄冠」）

https://scrip.pharmaintelligence.informa.com/SC147116/A-Banner-Moment-For-Alzheimers-Positions-EisaiBiogen-At-The-Head-Of-The-Pack

Lecanemab Conversion From Accelerated To Full Approval Could Be Among Fastest Ever

（邦題意訳「レカネマブ、史上最速で迅速承認から正式承認の切り替えを達成か」）

https://pink.pharmaintelligence.informa.com/PS147077/Lecanemab-Conversion-From-Accelerated-To-Full-Approval-Could-Be-Among-Fastest-Ever

【コンサルティングサービスのご紹介】

ファーマインテリジェンスのコンサルティングチームは、製薬やバイオ技術、医療機器といった分野で活躍する企業のお客様と緊密に連携し、個別の課題をピンポイントで解決します。開発途中の薬剤に関するビジネス機会評価や売上予測、価格予測をはじめ、医療経済評価モデルや臨床試験計画、ベンチマークの策定、協業戦略の策定やポートフォリオの優先順位評価など、幅広いニーズに応え、エビデンスに基づいた意思決定を支援します。今解決したい課題をお持ちの方、ぜひご相談ください。

担当者：今堀 逸太郎（[email protected]）